BR0113674A - Peptìdeos antiangiogênicos - Google Patents

Peptìdeos antiangiogênicos

Info

Publication number
BR0113674A
BR0113674A BR0113674-7A BR0113674A BR0113674A BR 0113674 A BR0113674 A BR 0113674A BR 0113674 A BR0113674 A BR 0113674A BR 0113674 A BR0113674 A BR 0113674A
Authority
BR
Brazil
Prior art keywords
peptides
adsgegdflaegggvrgprvverh
antiangiogenic
peptide
antiangiogenic peptides
Prior art date
Application number
BR0113674-7A
Other languages
English (en)
Inventor
Carolyn Staton
Claire Lewis
Jeffery Robinson
Original Assignee
Bioacta Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0021475A external-priority patent/GB0021475D0/en
Priority claimed from GB0027395A external-priority patent/GB0027395D0/en
Priority claimed from GB0117737A external-priority patent/GB0117737D0/en
Application filed by Bioacta Ltd filed Critical Bioacta Ltd
Publication of BR0113674A publication Critical patent/BR0113674A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"PEPTìDEOS ANTIANGIOGêNICOS". A presente invenção refere-se a peptídeos antiangiogênicos derivados de fibrinogênio; composições farmacêuticas compreendendo os referidos peptídeos; ácidos nucléicos codificando os referidos peptídeos e métodos para tratar animais, preferivelmente seres humanos, sofrendo de doenças que se beneficiariam da inibição da angiogênese. Seq³ência do DNA de <244>1-24; GCAGATAGTGGTGAAGGTGACTTTCTAGCTGAAGGAGGAGGC GTGCGTGGCCCAAGGGTTGTGGAAAGACAT Peptídeo <244>1-24; ADSGEGDFLAEGGGVRGPRVVERH Variantes do peptídeo <244>1-24. ADSGEGDFLAEGGGVRGPRVVERH ADSGEGDFLAEGGGVRGPRVVEXH ADSGEGDFLAEGGGVRGPXVVERH ADSGEGDFLAEGGGVRGXRVVERH ADSGEGDFLAEGGGVXGPRVVERH ADSGEGXFLAEGGGVRGPRVVERH ADSGEXDFLAEGGGVRGPRVVERH ADSXEGDFLAEGGGVRGPRVVERH ADSXEXDFLAEGGGVRXPRVVERH ADSGEGXFLAEGGGVRGPXVVERH
BR0113674-7A 2000-09-01 2001-09-03 Peptìdeos antiangiogênicos BR0113674A (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0021475A GB0021475D0 (en) 2000-09-01 2000-09-01 Anti-aniogenic peptides
GB0027395A GB0027395D0 (en) 2000-11-09 2000-11-09 Anti-angiogenic peptides
US25289600P 2000-11-27 2000-11-27
GB0117737A GB0117737D0 (en) 2001-07-23 2001-07-23 Modified peptides
PCT/GB2001/003926 WO2002018440A1 (en) 2000-09-01 2001-09-03 Anti-angiogenic peptides

Publications (1)

Publication Number Publication Date
BR0113674A true BR0113674A (pt) 2003-06-03

Family

ID=27447880

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0113674-7A BR0113674A (pt) 2000-09-01 2001-09-03 Peptìdeos antiangiogênicos

Country Status (8)

Country Link
EP (1) EP1315755A1 (pt)
JP (1) JP2004512832A (pt)
CN (1) CN1592755A (pt)
AU (1) AU2001284235A1 (pt)
BR (1) BR0113674A (pt)
CA (1) CA2420765A1 (pt)
IL (1) IL154609A0 (pt)
WO (1) WO2002018440A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050118598A1 (en) * 2002-02-19 2005-06-02 Carlos Garcia-Echeverria Organic compounds
GB0217018D0 (en) * 2002-07-23 2002-08-28 Bioacta Ltd Peptide 1
FR2846659B1 (fr) * 2002-10-30 2005-02-18 Centre Nat Rech Scient Fragments peptidiques du facteur harp inhibant l'angiogenese
US7785601B2 (en) * 2002-12-31 2010-08-31 Sygnis Bioscience Gmbh & Co. Kg Methods of treating neurological conditions with hematopoietic growth factors
ATE484520T1 (de) * 2007-04-11 2010-10-15 Gene Signal Int Sa Antitumorheilmittel, medikament, zusammensetzung und verwendung davon
US8372810B2 (en) 2007-04-11 2013-02-12 Gene Signal International Sa Anti-tumor drug, medicament, composition, and use thereof
CA2683463A1 (en) * 2007-04-11 2008-10-23 Gene Signal International Sa Anti-tumor variants and fragments of protein 497c, and uses thereof
CN107973839B (zh) * 2017-12-11 2020-09-04 暨南大学 抑制恶性肿瘤并增强化药疗效的活性肽及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639940A (en) * 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
WO1999048924A1 (en) * 1998-03-24 1999-09-30 The Children's Medical Center Corporation Endostatin derived peptides with anti-angiogenic and anti-cancer activity

Also Published As

Publication number Publication date
CN1592755A (zh) 2005-03-09
AU2001284235A1 (en) 2002-03-13
WO2002018440A1 (en) 2002-03-07
IL154609A0 (en) 2003-09-17
CA2420765A1 (en) 2002-03-07
EP1315755A1 (en) 2003-06-04
JP2004512832A (ja) 2004-04-30

Similar Documents

Publication Publication Date Title
BR0115427A (pt) Composto, composição farmacêutica, métodos para inibir a liberação de peptìdeo beta-amilóide e/ou sua sìntese, para tratar a doença de alzheimer, e para prevenir a doença e o progresso da doença de alzheimer, e, uso de um composto
TR200101032T2 (tr) Bitkilerdeki sağaltıcı yönden aktif proteinler.
BR0112666A (pt) Peptìdeos como inibidores de ns3-serina protease de vìrus da hepatite c
BR0201719A (pt) Composições farmacêuticas agradáveis ao paladar para animais de companhia
HUP0000492A1 (hu) N-(Aril/heteroaril-acetil)-aminosav-észterek, azokat tartalmazó gyógyászati készítmények, valamint módszerek béta-amiloid fehérje képződése és felszabadulása gátlására e vegyületek felhasználásával
NO20042298L (no) Farmasoytiske preparater og deres anvendelser
ES2193337T3 (es) Utilizacion de sales de estroncio para el tratamiento de la artrosis.
BR9713400A (pt) Processos e compostos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese.
BR0016935A (pt) Uso de derivados de ácido fumárico para tratamento de doenças mitocondriais
BR9714358A (pt) Derivados de n- (arila/heteroarila) amino ácido,composições farmacêuticas compreendendo os mesmos, e métodos para a inibição de liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
LU93259I2 (fr) LETIFEND (Protein Q)
SE0002202D0 (sv) New peptides
CY1109881T1 (el) Νεοαγγειακα-συγκεκριμενα πεπτιδια
BR0113674A (pt) Peptìdeos antiangiogênicos
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
BR0115424A (pt) Composto, composição farmacêutica, métodos para inibir a liberação de peptìdeo beta-amilóide e/ou sua sìntese, para tratar a doença de alzheimer, para prevenir a doença de alzheimer, e para inibir o progresso da doença de alzheimer, processos para preparar o composto, e para preparar lactamas, e, uso do composto
ATE225171T1 (de) Aminosäurederivate zur behandlung von schlaganfall
BR0109783A (pt) Tratamento de doenças renais
BR9711540A (pt) Inibidores de protease proteìnico estabilizados e variantes dos mesmos
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
BR0109279A (pt) Antagonistas de lhrh, sua preparação e aplicação como medicamento
UY26911A1 (es) Ácidos amino (oxo) acéticos inhibidores de la proteina tirosina fosfatasa
ATE346091T1 (de) Neues diagnostisches reagens und kit zur erkennung von rickettsiose
DK0811068T3 (da) Humane DNase I varianter
ATE328082T1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2021 DE 29/09/2009.